XML 93 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Preferred Stock - Additional Information (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 12 Months Ended
Oct. 01, 2021
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Jul. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
Oct. 08, 2021
$ / shares
Mar. 05, 2021
$ / shares
Jun. 30, 2019
$ / shares
shares
Temporary Equity [Line Items]              
Net proceeds from issuance of convertible preferred stock       $ 151,581      
Initial Public Offering | Common Stock              
Temporary Equity [Line Items]              
Share sale price per share | $ / shares         $ 16.00    
Securities Purchase Agreement | Series A Convertible Preferred Stock              
Temporary Equity [Line Items]              
Share sale price per share | $ / shares     $ 0.9681       $ 0.9681
Shares issued | shares     22,724,925       22,724,925
Gross cash proceeds from issuance of convertible preferred stock     $ 22,000        
Issuance costs     100        
Net proceeds from issuance of convertible preferred stock     $ 21,900        
Reverse stock split description 1-for-6.359 reverse stock split            
Reverse stock split, conversion ratio 0.15725743            
Securities Purchase Agreement | Series A Convertible Preferred Stock | Initial Public Offering              
Temporary Equity [Line Items]              
Number of preferred shares conversion | shares 22,724,925            
Securities Purchase Agreement | Series A Convertible Preferred Stock | Initial Public Offering | Common Stock              
Temporary Equity [Line Items]              
Convertible preferred stock shares issued upon conversion | shares 3,573,659            
Securities Purchase Agreement | Series B Convertible Preferred Stock              
Temporary Equity [Line Items]              
Share sale price per share | $ / shares   $ 1.6458       $ 1.6458  
Shares issued | shares   92,356,299          
Gross cash proceeds from issuance of convertible preferred stock   $ 152,000          
Issuance costs   400          
Net proceeds from issuance of convertible preferred stock   $ 151,600          
Reverse stock split description 1-for-6.359 reverse stock split            
Reverse stock split, conversion ratio 0.15725743            
Securities Purchase Agreement | Series B Convertible Preferred Stock | Initial Public Offering              
Temporary Equity [Line Items]              
Number of preferred shares conversion | shares 104,812,248            
Securities Purchase Agreement | Series B Convertible Preferred Stock | Initial Public Offering | Common Stock              
Temporary Equity [Line Items]              
Convertible preferred stock shares issued upon conversion | shares 16,482,486            
Agreements with Pfizer, Inc. and LegoChem | Series B Convertible Preferred Stock              
Temporary Equity [Line Items]              
Shares issued | shares   12,455,949          
Net proceeds from issuance of convertible preferred stock   $ 20,500